IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caligan Partners LP

Q2 2023 Holdings

Filed 2023-08-14 | 13 holdings | $177.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Liquidia Corp(LQDA)COM NEW53635D202$72.6M9,243,62740.8%
Anika Therapeutics Inc(ANIK)COM035255108$18.7M720,29110.5%
Exelixis Inc(EXEL)COM30161Q104$17.4M910,7309.8%
Standard Biotools Inc(LAB)COM34385P108$16.3M8,467,9209.2%
Intercept Pharmaceuticals Inc(ICPTUSD)COM45845P108$14.3M1,293,5108.0%
Intercept Pharmaceuticals IncPutPUT45845P958$13.3M1,200,0007.5%
Evolus Inc(EOLS)COM30052C107$12.8M1,760,1367.2%
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$3.9M183,0642.2%
Adma Biologics Inc(ADMA)COM000899104$3.1M847,5131.8%
Eyepoint Pharmaceuticals Inc(EYPT)COM NEW30233G209$2.7M310,2981.5%
Alimera Sciences IncCOM NEW016259202$1.4M478,7770.8%
Societal Cdmo IncCOM75629F109$1.2M1,077,2680.7%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$136.9K4,8330.1%